All In MedTech

Company

Corin

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Corin, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Corin.

Latest FDA decisions

The 8 newest of 37 since 2015.

Search the Clearance Tracker

34 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT05686278 · 368 participants (planned) · Start Jun 29, 2023 · Primary completion Sep 2028

    Device: Bipolar i and cemented stem (Océane+ or Meije) · For: Hip Fractures; Hip Hemiarthroplasty; Osteoarthritis, Hip and 2 more

    Sites: Amboise, France; Hénin-Beaumont, France; Paris, France · 4 sites in all

  • NCT06518993 · 116 participants · Start Apr 19, 2024 · Primary completion Jun 20, 2025

    Device: Total hip arthroplasty with a Trinity cup and a Meije Duo cementless stem · For: Hip Arthritis; Osteoarthritis, Hip; Coxitis and 2 more

    Sites: Valenciennes, France

  • NCT06203756 · 713 participants (planned) · Start Nov 9, 2017 · Primary completion Jan 1, 2029

    Device: Omnibotics Robotic-assisted Total Knee Arthroplasty with Apex UC; Omnibotics Robotic-assisted Total Knee Arthroplasty with Apex PS and 1 more · For: Arthroplasties, Knee Replacement; Revision Arthroplasty

    Sites: Flagstaff, Arizona; Middlebury, Connecticut; Rochester, Michigan · 6 sites in all

14 more trials with a free account

Reports received

185

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

7

3.8% of reports

Injury reports

178

96% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230500
Jan 240800
Feb 2411000
Mar 2411000
Apr 243700
May 2411300
Jun 2421000
Jul 2441100
Aug 240900
Sep 2431100
Oct 240700
Nov 2441200
Dec 240900
Jan 2521300
Feb 2511700
Mar 2522000
Apr 2521100
May 2501500
Jun 2522000
Jul 2521800
Aug 2521900
Sep 2511800
Oct 2501200
Nov 2521200
Dec 2503000
Jan 260700
Feb 2602300
Mar 2601500
Apr 261800
May 262500
Jun 2611100
Jul 2601700
Aug 2611700
Sep 2601900
Oct 2601400
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

23 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.